Authors
Jungbin Song, Seok-Jin Cho, Dong Wook Kang, Ju Hee Kim, Hocheol Kim, Hyewon Chung, Hea-Young Cho
Published in
Integrative medicine research. Volume 15. Issue 4. Pages 101370. Epub Jun 14, 2026.
Abstract
Banhabaekchulcheonmatang (BBCT) and Hwangryeonhaedoktang (HRHDT) are traditional herbal medicines widely used in East Asia to treat post-stroke sequelae. This study evaluated the effects of BBCT and HRHDT on the pharmacokinetics of atorvastatin, a drug commonly prescribed for secondary stroke prevention.
An open-label, randomized, three-period, two-sequence trial was conducted in 14 healthy Korean participants. In the first period, participants received a single 40 mg dose of atorvastatin. In subsequent periods, BBCT or HRHDT was administered three times daily for five days, followed by co-administration with atorvastatin on day 6. Plasma concentrations of atorvastatin and its active metabolites were measured, and pharmacokinetic parameters were determined using non-compartmental analysis.
Co-administration of BBCT reduced the maximum plasma concentration (Cmax) of atorvastatin by 24% without affecting the area under the plasma concentration-time curve (AUC), whereas HRHDT decreased atorvastatin Cmax, AUClast, and AUCinf by 46.7%, 22.6%, and 21.1%, respectively. BBCT or HRHDT co-administration also reduced the Cmax, AUClast, and AUCinf of 2-hydroxy atorvastatin by 30.2% and 52.7%, 14.9% and 35.9%, and 14.8% and 32.0%, respectively.
Co-administration of atorvastatin with BBCT or HRHDT resulted in a weak-to-moderate reduction in systemic exposure to atorvastatin and 2-hydroxy atorvastatin, suggesting that careful monitoring may be warranted during concomitant use.
Clinical Research Information Service (CRIS), Republic of Korea (KCT0008735).
PMID:
43034617
Bibliographic data and abstract were imported from PubMed on 15 Nov 2026.
Read full publication at:
Please sign in
to see all details.
Advertisement
Stats
- Recommendations n/a n/a positive of 0 vote(s)
- Views 11
- Comments 0